PGC-1α provides a transcriptional framework for synchronous neurotransmitter release from parvalbumin-positive interneurons

Journal of Neuroscience

Volumn 34, Issue 43, 2014, Pages 14375-14387

  Lucas, Elizabeth K ^a   Dougherty, Sarah E ^a   McMeekin, Laura J ^a   Reid, Courtney S ^a   Dobrunz, Lynn E ^a   West, Andrew B ^a   Hablitz, John J ^a   Cowell, Rita M ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Barnes maze; cortical development; Huntington disease; Ppargc1a; Schizophrenia; Strontium

Indexed keywords

4 AMINOBUTYRIC ACID; ADENYLATE KINASE 1; ATP SYNTHASE MITOCHONDRIAL F1 COMPLEX O SUBUNIT; ATP SYNTHASE MITROCHONDRIAL F1 COMPLEX ALPHA SUBUNIT 1; CHOLESTEROL ESTERASE; COMPLEXIN 1; NEUROFILAMENT PROTEIN; PARVALBUMIN; PEPTIDES AND PROTEINS; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PHYTANOL COA 2HYDROXYLASE; SYNAPTOJANIN; SYNAPTOTAGMIN II; UNCLASSIFIED DRUG; PPARGC1A PROTEIN, MOUSE; TRANSCRIPTION FACTOR;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; INTERNEURON; LONG TERM MEMORY; MALE; MICROARRAY ANALYSIS; MOUSE; NEUROBLASTOMA CELL; NEUROTRANSMITTER RELEASE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; UPREGULATION; WESTERN BLOTTING; WHOLE CELL PATCH CLAMP; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; GENETIC TRANSCRIPTION; KNOCKOUT MOUSE; METABOLISM; PHYSIOLOGY; SECRETION (PROCESS); TRANSGENIC MOUSE; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; GAMMA-AMINOBUTYRIC ACID; HUMANS; INTERNEURONS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; PARVALBUMINS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 84908065151     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.1222-14.2014     Document Type: Article

References (77)

1. Alcántara S, Ferrer I, Soriano E (1993) Postnatal development of parvalbumin and calbindin D28K immunoreactivities in the cerebral cortex of the rat. Anat Embryol 188:63–73. Medline
2. Atluri PP, Regehr WG (1998) Delayed release of neurotransmitter from cerebellar granule cells. J Neurosci 18:8214–8227. Medline
3. Behrends JC, ten Bruggencate G (1998) Changes in quantal size distributions upon experimental variations in the probability of release at striatal inhibitory synapses. J Neurophysiol 79:2999-3011. Medline
4. Berton F, Iborra C, Boudier JA, Seagar MJ, Marquèze B (1997) Developmental regulation of synaptotagmin I, II, III, and IV mRNAs in the rat CNS. J Neurosci 17:1206-1216. Medline
5. Blackwood DH, He L, Morris SW, McLean A, Whitton C, Thomson M, Walker MT, Woodburn K, Sharp CM, Wright AF, Shibasaki Y, St Clair DM, Porteous DJ, Muir WJ (1996) A locus for bipolar affective disorder on chromosome 4p. Nat Genet 12:427-430. CrossRef Medline
6. Blue ME, Parnavelas JG (1983) The formation and maturation of synapses in the visual cortex of the rat. II. Quantitative analysis. J Neurocytol 12: 697–712. CrossRef Medline
7. Cardin JA, Carlén M, Meletis K, Knoblich U, Zhang F, Deisseroth K, Tsai LH, Moore CI (2009) Driving fast-spiking cells induces gamma rhythm and controls sensory responses. Nature 459:663-667. CrossRef Medline
8. Carlén M, Meletis K, Siegle JH, Cardin JA, Futai K, Vierling-Claassen D, Rühlmann C, Jones SR, Deisseroth K, Sheng M, Moore CI, Tsai LH (2012) A critical role for NMDA receptors in parvalbumin interneurons for gamma rhythm induction and behavior. Mol Psychiatry 17:537–548. CrossRef Medline
9. Chaturvedi RK, Adhihetty P, Shukla S, Hennessy T, Calingasan N, Yang L, Starkov A, Kiaei M, Cannella M, Sassone J, Ciammola A, Squitieri F, Beal MF (2009) Impaired PGC-1alpha function in muscle in Huntington’s disease. Hum Mol Genet 18:3048-3065. CrossRef Medline
10. Cheng A, Wan R, Yang JL, Kamimura N, Son TG, Ouyang X, Luo Y, Okun E, Mattson MP (2012) Involvement of PGC-1alpha in the formation and maintenance of neuronal dendritic spines. Nat Commun 3:1250. CrossRef Medline
11. Christoforou A, Le Hellard S, Thomson PA, Morris SW, Tenesa A, Pickard BS, Wray NR, Muir WJ, Blackwood DH, Porteous DJ, Evans KL (2007) Association analysis of the chromosome 4p15–p16 candidate region for bipolar disorder and schizophrenia. Mol Psychiatry 12:1011–1025. CrossRef Medline
12. Christoforou A, McGhee KA, Morris SW, Thomson PA, Anderson S, McLean A, Torrance HS, Le Hellard S, Pickard BS, StClair D, Muir WJ, Blackwood DH, Porteous DJ, Evans KL (2011) Convergence of linkage, association and GWAS findings for a candidate region for bipolar disorder and schizophrenia on chromosome 4p. Mol Psychiatry 16:240-242. CrossRef Medline
13. Clark J, Reddy S, Zheng K, Betensky RA, Simon DK (2011) Association of PGC-1alpha polymorphisms with age of onset and risk of Parkinson’s disease. BMC Med Gen 12:69. CrossRef Medline
14. Collin T, Chat M, Lucas MG, Moreno H, Racay P, Schwaller B, Marty A, Llano I (2005) Developmental changes in parvalbumin regulate presynaptic Ca2[1] signaling. J Neurosci 25:96-107. CrossRef Medline
15. Constantinescu R, Zetterberg H, Holmberg B, Rosengren L (2009) Levels of brain related proteins in cerebrospinal fluid: an aid in the differential diagnosis of parkinsonian disorders. Parkinsonism Relat Disord 15:205-212. CrossRef Medline
16. Cowell RM, Blake KR, Russell JW (2007) Localization of the transcriptional coactivator PGC-1alpha to GABAergic neurons during maturation of the rat brain. J Comp Neurol 502:1–18. CrossRef Medline
17. Cowell RM, Talati P, Blake KR, Meador-Woodruff JH, Russell JW (2009) Identification of novel targets for PGC-1alpha and histone deacetylase inhibitors in neuroblastoma cells. Biochem Biophys Res Commun 379: 578–582. CrossRef Medline
18. Cui L, Jeong H, Borovecki F, Parkhurst CN, Tanese N, Krainc D (2006) Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration. Cell 127:59–69. CrossRef Medline
19. de Lecea L, del RíoJ A, Soriano E (1995) Developmental expression of parvalbumin mRNA in the cerebral cortex and hippocampus of the rat. Brain Res Mol Brain Res 32:1–13. CrossRef Medline
20. Dempster EL, Pidsley R, Schalkwyk LC, Owens S, Georgiades A, Kane F, Kalidindi S, Picchioni M, Kravariti E, Toulopoulou T, Murray RM, Mill J (2011) Disease-associated epigenetic changes in monozygotic twins discordant for schizophrenia and bipolar disorder. Hum Mol Genet 20: 4786–4796. CrossRef Medline
21. Donato F, Rompani SB, Caroni P (2013) Parvalbumin-expressing basketcell network plasticity induced by experience regulates adult learning. Nature 504:272–276. CrossRef Medline
22. Dougherty SE, Hollimon JJ, McMeekin LJ, Bohannon AS, West AB, Lesort M, Hablitz JJ, Cowell RM (2014a) Hyperactivity and cortical disinhibition in mice with restricted expression of mutant huntingtin to parvalbuminpositive cells. Neurobiol Dis 62:160-171. CrossRef Medline
23. Dougherty SE, Bartley AF, Lucas EK, Hablitz JJ, Dobrunz LE, Cowell RM (2014b) Mice lacking the transcriptional coactivator PGC-1alpha exhibit alterations in inhibitory synaptic transmission in the motor cortex. Neuroscience 271:137–148. CrossRef Medline
24. Fox MA, Sanes JR (2007) Synaptotagmin I and II are present in distinct subsets of central synapses. J Comp Neurol 503:280-296. CrossRef Medline
25. Freeman W, Morton AJ (2004) Differential messenger RNA expression of complexins in mouse brain. Brain Res Bull 63:33-44. CrossRef Medline
26. Fuchs EC, Zivkovic AR, Cunningham MO, Middleton S, Lebeau FE, Bannerman DM, Rozov A, Whittington MA, Traub RD, Rawlins JN, Monyer H (2007) Recruitment of parvalbumin-positive interneurons determines hippocampal function and associated behavior. Neuron 53:591-604. CrossRef Medline
27. Fusco FR, Chen Q, Lamoreaux WJ, Figueredo-Cardenas G, Jiao Y, Coffman JA, Surmeier DJ, Honig MG, Carlock LR, Reiner A (1999) Cellular localization of huntingtin in striatal and cortical neurons in rats: lack of correlation with neuronal vulnerability in Huntington’s disease. J Neurosci 19:1189-1202. Medline
28. Giampà Giampa C, Middei S, Patassini S, Borreca A, Marullo F, Laurenti D, Bernardi G, Ammassari-Teule M, Fusco FR (2009) Phosphodiesterase type IV inhibition prevents sequestration of CREB binding protein, protects striatal parvalbumin interneurons and rescues motor deficits in the R6/2 mouse model of Huntington’s disease. Eur J Neurosci 29:902–910. CrossRef Medline
29. Glynn D, Drew CJ, Reim K, Brose N, Morton AJ (2005) Profound ataxia in complexin I knockout mice masks a complex phenotype that includes exploratory and habituation deficits. Hum Mol Genet 14:2369-2385. CrossRef Medline
30. Hagler DJ Jr, Goda Y (2001) Properties of synchronous and asynchronous release during pulse train depression in cultured hippocampal neurons. J Neurophysiol 85:2324-2334. Medline
31. Hefft S, Jonas P (2005) Asynchronous GABA release generates long-lasting inhibition at a hippocampal interneuron-principal neuron synapse. Nat Neurosci 8:1319-1328. CrossRef Medline
32. Hippenmeyer S, Vrieseling E, Sigrist M, Portmann T, Laengle C, Ladle DR, Arber S (2005) A developmental switch in the response of DRG neurons to ETS transcription factor signaling. PLoS Biol 3:e159. CrossRef Medline
33. Jiang Z, Rompala GR, Zhang S, Cowell RM, Nakazawa K (2013) Social isolation exacerbates schizophrenia-like phenotypes via oxidative stress in cortical interneurons. Biol Psychiatry 73:1024-1034. CrossRef Medline
34. Jones DG, Cullen AM (1979) A quantitative investigation of some presynaptic terminal parameters during synaptogenesis. Exp Neurol 64:245-259. CrossRef Medline
35. Kim J, Moody JP, Edgerly CK, Bordiuk OL, Cormier K, Smith K, Beal MF, Ferrante RJ (2010) Mitochondrial loss, dysfunction and altered dynamics in Huntington’s disease. Hum Mol Genet 19:3919-3935. CrossRef Medline
36. Korotkova T, Fuchs EC, Ponomarenko A, von Engelhardt J, Monyer H (2010) NMDA receptor ablation on parvalbumin-positive interneurons impairs hippocampal synchrony, spatial representations, and working memory. Neuron 68:557–569. CrossRef Medline
37. Lariviere RC, Julien JP (2004) Functions of intermediate filaments in neuronal development and disease. J Neurobiol 58:131–148. CrossRef Medline
38. Le Hellard S, Lee AJ, Underwood S, Thomson PA, Morris SW, Torrance HS, Anderson SM, Adams RR, Navarro P, Christoforou A, Houlihan LM, Detera-Wadleigh S, Owen MJ, Asherson P, Muir WJ, Blackwood DH, Wray NR, Porteous DJ, Evans KL (2007) Haplotype analysis and a novel allele-sharing method refines a chromosome 4p locus linked to bipolar affective disorder. Biol Psychiatry 61:797-805. CrossRef Medline
39. Lein ES, Hawrylycz MJ, Ao N, Ayres M, Bensinger A, Bernard A, Boe AF, Boguski MS, Brockway KS, Byrnes EJ, Chen L, Chen L, Chen TM, Chin MC, Chong J, Crook BE, Czaplinska A, Dang CN, Datta S, Dee NR, et al. (2007) Genome-wide atlas of gene expression in the adult mouse brain. Nature 445:168-176. CrossRef Medline
40. Leone TC, Lehman JJ, Finck BN, Schaeffer PJ, Wende AR, Boudina S, Courtois M, Wozniak DF, Sambandam N, Bernal-Mizrachi C, Chen Z, Holloszy JO, Medeiros DM, Schmidt RE, Saffitz JE, Abel ED, Semenkovich CF, Kelly DP (2005) PGC-1alpha deficiency causes multi-system energy metabolic derangements: muscle dysfunction, abnormal weight control and hepatic steatosis. PLoS Biol 3:e101. CrossRef Medline
41. Lewis DA, Hashimoto T, Volk DW (2005) Cortical inhibitory neurons and schizophrenia. Nat Rev Neurosci 6:312–324. CrossRef Medline
42. Lin J, Wu PH, Tarr PT, Lindenberg KS, St-Pierre J, Zhang CY, Mootha VK, Jäger S, Vianna CR, Reznick RM, Cui L, Manieri M, Donovan MX, Wu Z, Cooper MP, Fan MC, Rohas LM, Zavacki AM, Cinti S, Shulman GI, et al. (2004) Defects in adaptive energy metabolism with CNS-linked hyperactivity in PGC-1alpha null mice. Cell 119:121–135. CrossRef Medline
43. Lin J, Handschin C, Spiegelman BM (2005) Metabolic control through the PGC-1 family of transcription coactivators. Cell Metab 1:361–370. CrossRef Medline
44. Lin JD (2009) Minireview: the PGC-1 coactivator networks: chromatinremodeling and mitochondrial energy metabolism. Mol Endocrinol 23: 2–10. CrossRef Medline
45. Lu T, Trussell LO (2000) Inhibitory transmission mediated by asynchronous transmitter release. Neuron 26:683-694. CrossRef Medline
46. Lucas EK, Markwardt SJ, Gupta S, Meador-Woodruff JH, Lin JD, Overstreet- Wadiche L, Cowell RM (2010) Parvalbumin deficiency and GABAergic dysfunction in mice lacking PGC-1alpha. J Neurosci 30:7227–7235. CrossRef Medline
47. Lucas EK, Dougherty SE, McMeekin LJ, Trinh AT, Reid CS, Cowell RM (2012) Developmental alterations in motor coordination and medium spiny neuron markers in mice lacking pgc-1alpha. PloS One 7:e42878. CrossRef Medline
48. Luthi-Carter R, Hanson SA, Strand AD, Bergstrom DA, Chun W, Peters NL, Woods AM, Chan EY, Kooperberg C, Krainc D, Young AB, Tapscott SJ, Olson JM (2002) Dysregulation of gene expression in the R6/2 model of polyglutamine disease: parallel changes in muscle and brain. Hum Mol Genet 11:1911–1926. CrossRef Medline
49. Manseau F, Marinelli S, Mendez P, Schwaller B, Prince DA, Huguenard JR, Bacci A (2010) Desynchronization of neocortical networks by asynchronous release of GABA at autaptic and synaptic contacts from fast-spiking interneurons. PLoS Biol 8:e1000492.
50. Maximov A, Tang J, Yang X, Pang ZP, Südhof TC (2009) Complexin controls the force transfer from SNARE complexes to membranes in fusion. Science 323:516-521. CrossRef Medline
51. Monsalve M, Wu Z, Adelmant G, Puigserver P, Fan M, Spiegelman BM (2000) Direct coupling of transcription and mRNA processing through the thermogenic coactivator PGC-1. Mol Cell 6:307–316. CrossRef Medline
52. Muzumdar MD, Tasic B, Miyamichi K, Li L, Luo L (2007) A global doublefluorescent Cre reporter mouse. Genesis 45:593-605. CrossRef Medline
53. Pabst S, Hazzard JW, Antonin W, Südhof TC, Jahn R, Rizo J, Fasshauer D (2000) Selective interaction of complexin with the neuronal SNARE complex. Determination of the binding regions. J Biol Chem 275:19808-19818. CrossRef Medline
54. Pang ZP, Melicoff E, Padgett D, Liu Y, Teich AF, Dickey BF, Lin W, Adachi R, Südhof TC (2006) Synaptotagmin-2 is essential for survival and contributes to Ca2[1] triggering of neurotransmitter release in central and neuromuscular synapses. J Neurosci 26:13493–13504. CrossRef Medline
55. Qin W, Haroutunian V, Katsel P, Cardozo CP, Ho L, Buxbaum JD, Pasinetti GM (2009) PGC-1alpha expression decreases in the Alzheimer disease brain as a function of dementia. Arch Neurol 66:352–361. CrossRef Medline
56. Reim K, Mansour M, Varoqueaux F, McMahon HT, Südhof TC, Brose N, Rosenmund C (2001) Complexins regulate a late step in Ca2+- dependent neurotransmitter release. Cell 104:71-81. CrossRef Medline
57. Róna-Vörös K, Weydt P (2010) The role of PGC-1alpha in the pathogenesis of neurodegenerative disorders. Curr Drug Targets 11:1262–1269. CrossRef Medline
58. Rumpel E, Behrends JC (1999) Sr2+-dependent asynchronous evoked transmission at rat striatal inhibitory synapses in vitro. J Physiol 514:447-458. CrossRef Medline
59. Shaw G, Weber K (1982) Differential expression of neurofilament triplet proteins in brain development. Nature 298:277–279. CrossRef Medline
60. Shin JH, Ko HS, Kang H, Lee Y, Lee YI, Pletinkova O, Troconso JC, Dawson VL, Dawson TM (2011) PARIS (ZNF746) repression of PGC-1alpha contributes to neurodegeneration in Parkinson’s disease. Cell 144:689-702. CrossRef Medline
61. Sohal VS, Zhang F, Yizhar O, Deisseroth K (2009) Parvalbumin neurons and gamma rhythms enhance cortical circuit performance. Nature 459: 698–702. CrossRef Medline
62. St-Pierre J, Drori S, Uldry M, Silvaggi JM, Rhee J, Jäger S, Handschin C, Zheng K, Lin J, Yang W, Simon DK, Bachoo R, Spiegelman BM (2006) Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators. Cell 127:397-408. CrossRef Medline
63. Su J, Gorse K, Ramirez F, Fox MA (2010) Collagen XIX is expressed by interneurons and contributes to the formation of hippocampal synapses. J Comp Neurol 518:229-253. Medline
64. Sun J, Pang ZP, Qin D, Fahim AT, Adachi R, Südhof TC (2007) A dual- Ca2+-sensor model for neurotransmitter release in a central synapse. Nature 450:676–682. CrossRef Medline
65. Taherzadeh-Fard E, Saft C, Andrich J, Wieczorek S, Arning L (2009) PGC- 1alpha as modifier of onset age in Huntington disease. Mol Neurodegener 4:10. CrossRef Medline
66. Tamás G, Buhl EH, Lörincz A, Somogyi P (2000) Proximally targeted GABAergic synapses and gap junctions synchronize cortical interneurons. Nat Neurosci 3:366-371. CrossRef Medline
67. Tang J, Maximov A, Shin OH, Dai H, Rizo J, Südhof TC (2006) A complexin/ synaptotagmin 1 switch controls fast synaptic vesicle exocytosis. Cell 126:1175–1187. CrossRef Medline
68. Weydt P, Pineda VV, Torrence AE, Libby RT, Satterfield TF, Lazarowski ER, Gilbert ML, Morton GJ, Bammler TK, Strand AD, Cui L, Beyer RP, Easley CN, Smith AC, Krainc D, Luquet S, Sweet IR, Schwartz MW, La Spada AR (2006) Thermoregulatory and metabolic defects in Huntington’s disease transgenic mice implicate PGC-1alpha in Huntington’s disease neurodegeneration. Cell Metab 4:349-362. CrossRef Medline
69. Weydt P, Soyal SM, Gellera C, Didonato S, Weidinger C, Oberkofler H, Landwehrmeyer GB, Patsch W (2009) The gene coding for PGC-1alpha modifies age at onset in Huntington’s disease. Mol Neurodegener 4:3. CrossRef Medline
70. Weydt P, Soyal SM, Landwehrmeyer GB, Patsch W (2014) A single nucleotide polymorphism in the coding region of PGC-1alpha is a male-specific modifier of Huntington disease age-at-onset in a large European cohort. BMC Neurol 14:1. CrossRef Medline
71. Whittaker RG, Turnbull DM, Whittington MA, Cunningham MO (2011) Impaired mitochondrial function abolishes gamma oscillations in the hippocampus through an effect on fast-spiking interneurons. Brain 134: e180; author reply e181. CrossRef Medline
72. Wierzbicki AS (2007) Peroxisomal disorders affecting phytanic acid alphaoxidation: a review. Biochem Soc Trans 35:881-886. CrossRef Medline
73. Xu J, Mashimo T, Südhof TC (2007) Synaptotagmin-1, -2, and -9: Ca(2+) sensors for fast release that specify distinct presynaptic properties in subsets of neurons. Neuron 54:567–581. CrossRef Medline
74. Xue M, Reim K, Chen X, Chao HT, Deng H, Rizo J, Brose N, Rosenmund C (2007) Distinct domains of complexin I differentially regulate neurotransmitter release. Nat Struct Mol Biol 14:949-958. CrossRef Medline
75. Yang X, Kaeser-Woo YJ, Pang ZP, Xu W, Südhof TC (2010) Complexin clamps asynchronous release by blocking a secondary Ca(2+) sensor via its accessory alpha helix. Neuron 68:907–920. CrossRef Medline
76. Zheng B, Liao Z, Locascio JJ, Lesniak KA, Roderick SS, Watt ML, Eklund AC, Zhang-James Y, Kim PD, Hauser MA, Grünblatt E, Moran LB, Mandel SA, Riederer P, Miller RM, Federoff HJ, Wüllner U, Papapetropoulos S, Youdim MB, Cantuti-Castelvetri I, et al. (2010) PGC-1alpha, a potential therapeutic target for early intervention in Parkinson’s disease. Sci Transl Med 2:52ra73. CrossRef Medline
77. Zhu Q, Lindenbaum M, Levavasseur F, Jacomy H, Julien JP (1998) Disruption of the NF-H gene increases axonal microtubule content and velocity of neurofilament transport: relief of axonopathy resulting from the toxin beta,beta’-iminodipropionitrile. J Cell Biol 143:183–193. CrossRef Medline